SOUTH SAN FRANCISCO, Calif., December 06, 2023 TeraPore Technologies, an innovator in nanofiltration membranes, has commercially launched the flagship IsoBlock® VF product line for parvovirus removal from biopharmaceuticals. During evaluations at multiple customer sites across different novel antibody constructs, IsoBlock VF has demonstrated robust and consistent performance. With both mammalian parvoviruses and surrogate bacteriophages, IsoBlock VF has shown high virus retention that appears u
Entegris joins a strong list of existing investors to help expand the use of the company’s next generation bioseparation solutions.SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) TeraPore Technologies, the developer of advanced nanofiltration membrane systems for biomanufacturing, today announced it has raised $10M in.